In conclusion, our study found the difference between TILs in DCIS and DCIS-Mi patients in the Chinese population, and focused on analyzing the characteristics of TILs in HER2 overexpressing tumors. The gene discussed is ERBB2; the disease is ductal breast carcinoma in situ.